Update on efficacy of allergen immunotherapy for allergic rhinitis and asthma

Carol Anne Saltoun*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Specific allergen immunotherapy (IT) has long been used to treat allergic rhinitis and asthma. Review of the literature from the past 5 years continues to support this use of IT as the only disease-modifying treatment of allergic disease currently available. In addition, studies suggest that allergen IT may prevent the progression of allergic disease. In monosensitized patients, IT may prevent polysensitization. In younger patients with allergic rhinitis only, IT may prevent the new onset of asthma. Although these studies require further validation, the evidence is important enough to consider disease prevention as one of the indications for prescribing allergen IT.

Original languageEnglish (US)
Pages (from-to)377-380
Number of pages4
JournalAllergy and Asthma Proceedings
Volume23
Issue number6
StatePublished - Nov 1 2002

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Update on efficacy of allergen immunotherapy for allergic rhinitis and asthma'. Together they form a unique fingerprint.

Cite this